Product Code Database
Asael Lubotzky (; born 1983) is an Israeli physician, author, and molecular biologist. Formerly an officer in the Israel Defense Forces (IDF), he is a Veteran of the Second Lebanon War.
Lubotzky conducted research in the lab of professor Haim Cedar and became a PhD student under Professor Yuval Dor and Ruth Shemer at the Hebrew University's Department of Developmental Biology and Cancer Research, who works on methylation patterns of circulating cell-free DNA (cfDNA). Lubotzky was recognized for his studies on cfDNA as cancer diagnostic markers, and his research has earned him several honors, including the Israel Cancer Research Fund (ICRF) cancer grant Hebrew U receives major portion of ICRF cancer research grants, Hebrew University of Jerusalem. Dr. Asael Lubotzky, MD, Israel Cancer Research Fund. and in 2019, he was awarded The James Sivartsen Prize in Cancer Research by The Hebrew University. The James Sivartsen Prize in Cancer Research, The Hebrew University, 2019.
In 2020 his research team received a prestigious grant of $500,000 from the Bill & Melinda Gates Foundation and Alzheimer's Drug Discovery Foundation towards their research on early diagnosis of Alzheimer's disease based on blood tests. Congratulations to Dr. Asael Lubotzky and the team of researchers from Hebrew University who were chosen to receive one of the grants for half a million dollars from the Bill & Melinda Gates Foundation, Shaare Zedek Medical Center news, February 26, 2020.
In 2021 he received the Joint Award of the National Institute of Psychobiology in Israel (NIPI) and the Israeli Society of Biological Psychiatry. Asael Lubotzy, MD, PhD, Hebrew University, Alzheimer's Drug Discovery Foundation, 2021.
In 2021 he was awarded a PhD for a thesis entitled: "Liquid Biopsies Reveal Collateral Tissue Damage in Cancer and Brain Damage in Neural Pathologies". PhD Thesis Defense - Dr. Asael Lubotzky, The Department of Developmental Biology and Cancer Research, The Hebrew University, 2021. His findings demonstrated that metastatic tumors cause collateral tissue damage, releasing cfDNA from affected organs, and that cfDNA methylation patterns can help pinpoint metastases and their tissue origins.
In 2022 he received The Rothschild Fellowship for young scholars of outstanding academic merit. Rothschild Fellows, Yad Hanadiv, 2022. In the same year, Lubotzky and his colleagues published a study showing that brain cells die during Psychosis episodes, with higher levels of brain-derived cfDNA detected in patients experiencing psychotic symptoms, compared to healthy controls. The finding would serve as a proof of concept for brain-derived cell-free DNA as biomarkers of psychosis.
In 2023, Lubotzky received the Ben Barres Spotlight Award by eLife for his research towards understanding brain dynamics. Ben Barres Spotlight Awards: Announcing the winners for 2023, eLife, 2023.
Lubotzky won the Leitersdorf Prize for the Arts for 2017. Dr. Lubotzky won The Leitersdorf Award for significant contribution to the arts, Shaare Zedek Medical Center, July 2017. Lubotzky lectures on various topics in Israel and internationally. Inspirational speaker, Asael Lubotzky, M.D., who spoke about his victory overcoming medical injuries received in the 2006 Lebanon War, American Healthcare Professionals and Friends for Medicine in Israel, December 16, 2012. Physician shows medical Birthright group that blending profession and Judaism works, The Jewish News, January 10, 2015. A Hero's Struggle – Dr. Asael Lubotzky, Rohr Jewish Learning Institute.
|
|
